期刊文献+

人乳头瘤病毒疫苗防治宫颈癌研究的新进展 被引量:1

New advances of HPV vaccine in treatment and prevention of cervical cancer
下载PDF
导出
摘要 宫颈癌的发病率在女性恶性肿瘤居第二位 ,人乳头状瘤病毒 (HPV)感染已被证实为宫颈癌发生的主要因素 ,采用HPV疫苗防治HPV感染和宫颈癌是最根本的病因治疗方法 ,其中HPV疫苗分为预防性疫苗和治疗性疫苗两大类 ,本文综述了近几年关于HPV疫苗的研究成果。 Cervical cancer remains the second leading cause of cancer related deaths among women across the world.It has been approved that infection of human papillomaviruses(HPV)is necessary for the development of cervical cancer.So an effective vaccine against HPV may be the most radical etiological treatment to HPV infection and cervical cancer.These vaccines can be divided into prophylactic vaccines and therapeutic vaccines.This review will concentrate on the most recent advances in HPV vaccines.
出处 《癌症进展》 2004年第5期339-342,共4页 Oncology Progress
关键词 人类乳头状瘤病毒 宫颈癌 疫苗 human papillomaviruses cervical carcinoma vaccine
  • 相关文献

参考文献20

  • 1[1]Walboomers JM, Jacobs MV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 1999, 189:12 被引量:1
  • 2[2]Crish JE, Bone E, Balasubramanian S, et al. Suprabasal expression of the human papillomavirus type 16 oncoproteins in mouse epidermits alters expression of cell cycle regulatory proteins. Carcinogenesis, 2000, 21: 1031 被引量:1
  • 3[3]Harro CD, Pang YY, Roden RB, et al. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus - like particle vaccine. J Natl Cancer Inst, 2001, 93: 284 被引量:1
  • 4[4]Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med,2002, 347:1645 被引量:1
  • 5[5]Pinto LA, Edwards J, Castle PE, et al. Cellular immune responses to human papillomavirus (HPV) - 16 L1 in healthy volunteers immunized with recombinant HPV- 16 L1 virus- like particles. J Infect Dis, 2003, 188: 327 被引量:1
  • 6[6]Dale C J, Liu XS, Rose De R, et al. Chimeric human papillomavirus - simian/human immuno deficiency virus virus- like particle vaccines: Immunogenicity and protective efficacy in macaques. Virology, 2002, 301:176 被引量:1
  • 7[7]Fansch SC, Silva Da DM, Rudolf MP, et al. Human papillomavirus virus- like particles do not activate Langerhans cells: A possible immune escape mechanism used by human papillomaviruses. J Immunol, 2002, 169:3242 被引量:1
  • 8[8]Crum CP. The beginning of the end for cervical cancer? N Engl J Med, 2002, 347:1703 被引量:1
  • 9[9]Velders MP, Markiewicz M, Eiben GL, et al. CD4 T cell matters in tumor immunity. Int Rev Immunol, 2003, 22:113 被引量:1
  • 10[10]Ridge JP, Rosa Di F, and Matzinger P. A conditioned dentritic cell can be a temporal bridge between a CD4+ T helper and a T killer cell. Nature, 1998, 393:474 被引量:1

同被引文献5

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部